Chargement en cours...
Reimbursement of orphan drugs in Belgium: what (else) matters?
BACKGROUND: Most orphan drugs do not meet traditional standards of cost-effectiveness. Yet, most orphan drugs are reimbursed, which implies that other factors are taken into account at the time of reimbursement. To increase accountability of decision-makers, there is a need for more transparency in...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4172832/ https://ncbi.nlm.nih.gov/pubmed/25208770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0139-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|